Tumor response and 4 year survival-data of patients with advanced renal-cell carcinoma treated with autologous tumor vaccine and subcutaneous R-IL-2 and IFN-alpha(2b).
about
Specific immunotherapy in renal cancer: a systematic review.Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines.Therapeutic potential of oncolytic Newcastle disease virus: a critical review.Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients.Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate!
P2860
Tumor response and 4 year survival-data of patients with advanced renal-cell carcinoma treated with autologous tumor vaccine and subcutaneous R-IL-2 and IFN-alpha(2b).
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Tumor response and 4 year surv ...... eous R-IL-2 and IFN-alpha(2b).
@ast
Tumor response and 4 year surv ...... eous R-IL-2 and IFN-alpha(2b).
@en
type
label
Tumor response and 4 year surv ...... eous R-IL-2 and IFN-alpha(2b).
@ast
Tumor response and 4 year surv ...... eous R-IL-2 and IFN-alpha(2b).
@en
prefLabel
Tumor response and 4 year surv ...... eous R-IL-2 and IFN-alpha(2b).
@ast
Tumor response and 4 year surv ...... eous R-IL-2 and IFN-alpha(2b).
@en
P2093
P1476
Tumor response and 4 year surv ...... neous R-IL-2 and IFN-alpha(2b)
@en
P2093
P304
P577
1995-05-01T00:00:00Z